Li Dan, Merchant Sophie A, Badalov Jessica M, Corley Douglas A
Division of Research, Kaiser Permanente Northern California, Oakland, California.
Department of Gastroenterology, The Permanente Medical Group, Kaiser Permanente Northern California, Santa Clara, California.
Gastro Hep Adv. 2024 Jul 29;3(6):749-760. doi: 10.1016/j.gastha.2024.04.008. eCollection 2024.
There are minimal recent population-based data on the epidemiology of () in the United States.
This retrospective cohort study evaluated positivity rates in adult members of a large, community-based US population in 2000-2019. Time trends, demographic disparities, and birth cohort effects on test positivity rates were analyzed.
Among 751,322 individuals tested for , the overall nonserological and serological test positivity rates were 18.2% (95% confidence interval [CI], 18.1%-18.4%) and 36.8% (95% CI, 36.6%-36.9%), respectively. Nonserological positivity rate (95% CI) was significantly higher among Asian (23.2% [22.8%-23.6%]), Black (25.1% [24.4%-25.8%]), and Hispanic (28.1% [27.7%-28.5%]) individuals than non-Hispanic White individuals (10.0% [9.8%-10.2%]), and was significantly higher among individuals with a non-English language preference (32.9% [32.3%-33.5%]) than those with English language preference (15.8% [15.6%-15.9%]). Patterns were similar for serological positivity, although with substantially higher rates. Serological positivity rates decreased over 2 decades but nonserological positivity rates initially decreased and then stabilized over the past decade. There was a significant decrease in both nonserological and serological positivity rates from older to younger birth cohorts. Older age, non-White race or Hispanic ethnicity, male sex, and non-English language preference were associated with high odds of positivity.
The burden of decreased over 2 decades, although the rates of active infection plateaued over the past decade in a diverse, community-based US population, likely attributable to birth cohort effects and demographic changes. Asian, Black, and Hispanic individuals had 2-3-fold higher rates of active infection than non-Hispanic White individuals. These findings should inform targeted screening and eradication of in high-risk US populations.
美国近期基于人群的[疾病名称]流行病学数据极少。
这项回顾性队列研究评估了2000 - 2019年美国一个大型社区人群中成年成员的[疾病名称]阳性率。分析了时间趋势、人口统计学差异以及出生队列对[疾病名称]检测阳性率的影响。
在751,322名接受[疾病名称]检测的个体中,总体非血清学和血清学检测阳性率分别为18.2%(95%置信区间[CI],18.1% - 18.4%)和36.8%(95% CI,36.6% - 36.9%)。亚洲人(23.2% [22.8% - 23.6%])、黑人(25.1% [24.4% - 25.8%])和西班牙裔(28.1% [27.7% - 28.5%])个体的非血清学阳性率(95% CI)显著高于非西班牙裔白人个体(10.0% [9.8% - 10.2%]),且非英语偏好个体(32.9% [32.3% - 33.5%])的非血清学阳性率显著高于英语偏好个体(15.8% [15.6% - 15.9%])。血清学阳性情况的模式相似,不过比率要高得多。血清学阳性率在20年里有所下降,但非血清学阳性率在过去十年中最初下降然后趋于稳定。从年长到年轻的出生队列,非血清学和血清学阳性率均显著下降。年龄较大、非白人种族或西班牙裔族裔、男性以及非英语偏好与[疾病名称]阳性的高几率相关。
在20年里[疾病名称]负担有所减轻,尽管在一个多样化的美国社区人群中,过去十年活动性感染率趋于平稳,这可能归因于出生队列效应和人口结构变化。亚洲人、黑人和西班牙裔个体的活动性[疾病名称]感染率比非西班牙裔白人个体高2至3倍。这些发现应为美国高危人群中有针对性的筛查和根除[疾病名称]提供参考。